deltatrials
Completed PHASE3 NCT00152854

Acetaminophen for Cancer Pain

A Randomised, Placebo-controlled, Crossover Trial of Acetaminophen in Cancer Patients on Strong Opioids

Sponsor: University Health Network, Toronto

Conditions Cancer Pain
Interventions Acetaminophen acetaminophen placebo, sugar pill
Updated 5 times since 2017 Last updated: Mar 4, 2016 Started: Jul 31, 2005 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

A PHASE3 clinical study on Cancer and Pain, this trial is completed. The trial is conducted by University Health Network, Toronto and has accumulated 5 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Health Network, Toronto
Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Sydney, Australia
  • • Toronto, Canada